Assessment of phosphatidylinositol-3 kinase (PI3K) as a prognostic marker in head and neck squamous cell carcinoma (HNSCC)

被引:1
|
作者
Pectasides, E.
Founztilas, G.
Sasaki, C.
Burtness, B.
Psyrri, A.
机构
[1] Yale Univ, New Haven, CT USA
[2] Aristotle Univ Thessaloniki, GR-54006 Thessaloniki, Greece
[3] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e17028
引用
收藏
页数:2
相关论文
共 50 条
  • [1] PI3K Inhibition for Squamous Cell Head and Neck Carcinoma
    Desilets, Antoine
    Soulieres, Denis
    CANCER JOURNAL, 2022, 28 (05): : 369 - 376
  • [2] Hyperglycemia secondary to phosphatidylinositol-3 kinase (PI3K) inhibition
    Sriravindrarajah, Arunan
    Hurwitz, Joshua
    Lim, Elgene
    Greenfield, Jerry R.
    ENDOCRINOLOGY DIABETES AND METABOLISM CASE REPORTS, 2024, 2024 (04):
  • [3] Inhibition of PI3K and MEK in Combination With Radiation Therapy in Murine Model of Head and Neck Squamous Cell Carcinoma (HNSCC)
    Blas, K. G.
    Galoforo, S.
    Krueger, S. A.
    Wilson, T. G.
    Grills, I. S.
    Marples, B.
    Wilson, G. D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E586 - E587
  • [4] Integrative drug sensitivity analysis of PI3K/mTOR pathway inhibitors in Head and Neck Squamous Cell Carcinoma (HNSCC)
    Sambandam, Vaishnavi
    Shen, Li
    Zhang, Ming
    Saigal, Rishi
    Byers, Lauren A.
    Pickering, Curtis
    Myers, Jeffrey N.
    Wang, Jing
    Johnson, Faye M.
    CANCER RESEARCH, 2015, 75
  • [5] The Role of the PI3K/Akt/mTOR Axis in Head and Neck Squamous Cell Carcinoma
    Jiang, Qian
    Xiao, Jingyi
    Hsieh, Yao-Ching
    Kumar, Neha Love
    Han, Lei
    Zou, Yuntao
    Li, Huang
    BIOMEDICINES, 2024, 12 (07)
  • [6] RAS/PI3K Crosstalk and Cetuximab Resistance in Head and Neck Squamous Cell Carcinoma
    Rampias, T.
    Giagini, A.
    Siolos, S.
    Matsuzaki, H.
    Sasaki, C.
    Scorilas, A.
    Psyrri, A.
    CLINICAL CANCER RESEARCH, 2014, 20 (11) : 2933 - 2946
  • [7] INVESTIGATING MECHANISMS OF PI3K INHIBITOR RESISTANCE IN HEAD AND NECK SQUAMOUS CELL CARCINOMA
    Vien, M.
    Young, C. D.
    Wang, X.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2018, 66 (01) : 110 - 110
  • [8] Targeting the PI3K/AKT/mTOR pathway in squamous cell carcinoma of the head and neck
    Simpson, Daniel R.
    Mell, Loren K.
    Cohen, Ezra E. W.
    ORAL ONCOLOGY, 2015, 51 (04) : 291 - 298
  • [9] Pharmacological PI3K inhibition in head and neck squamous cell carcinoma: A systematic review
    Alves, L. B.
    Moura, A. C.
    dos Santos, J. Amorim
    Borges, G. A.
    Guerra, E. N. S.
    TOXICOLOGY IN VITRO, 2023, 88
  • [10] Dysregulations in the PI3K pathway and targeted therapies for head and neck squamous cell carcinoma
    Cai, Yi
    Dodhia, Sonam
    Su, Gloria H.
    ONCOTARGET, 2017, 8 (13) : 22203 - 22217